南新制药：9月份公司未实施股份回购

Core Points - Nanjing New Pharmaceutical announced that it has not implemented share repurchase as of September 2025 [2] - As of September 30, 2025, the company has repurchased a total of 265,516 shares through the Shanghai Stock Exchange, which represents 0.10% of the total share capital [2]